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Abstract
Embryonic development is highly sensitive to xenobiotic toxicity and in utero exposure to 
environmental toxins affects physiological responses of the progeny. In the US, the prevalace of 
allergic asthma is inexplicably rising and in utero exposure to cigarette smoke (CS) increases the 
risk of allergic asthma (AA) and bronchopulmonary dysplasia (BPD) in children and animal 
models. We reported that gestational exposure to sidestream (secondhand) CS (SS) promoted 
nicotinic acetylcholine receptor-dependent exacerbation of AA and BPD in mice. Recently, 
perinatal nicotine injections in rats were reported to induce peroxisome proliferator-activated 
receptor gamma (PPARγ)-dependent transgenerational transmission of asthma. Herein, we show 
that F1 and F2 progeny from gestationally SS-exposed mice exhibit exacerbated AA and BPD that 
is not dependent on the decrease in PPARγ levels. Lungs from these mice show strong 
eosinophilic infiltration, excessive Th2 polarization, marked airway hyperresponsiveness, alveolar 
simplification, decreased lung compliance, and decreased lung angiogenesis. At the molecular 
level, these changes are associated with increased RUNX3 expression, alveolar cell apoptosis, and 
the antiangiogenic factor GAX, and decreased expression of HIF-1α and pro-angiogenic factors 
NF-κB and VEGFR2 in the 7-day F1 and F2 lungs. Moreover, the lungs from these mice exhibit 
lower levels of micro-RNA (miR)-130a and increased levels of miR-16 and miR-221. These miRs 
regulate HIF-1α-regulated apoptotic, angiogenic, and immune pathways. Thus the 
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intergenerational effects of gestational SS involve epigenetic regulation of HIF-1α through 
specific miRs contributing to increased incidence of AA and BPD in the progenies.
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RNAs
INTRODUCTION
Epidemiological studies suggest that some environmental toxicants affect fetal development 
and increase the susceptibility to lung diseases (1). Furthermore, exposure to some 
xenobiotics during pregnancy may adversely affects the health of children; some of these 
effects are transmittable to subsequent generations (2, 3). Maternal smoking during 
pregnancy remains relatively common (4, 5) and the risk of cigarette smoke (CS)-associated 
pulmonary complications are highest in the lungs that are exposed to CS in utero (6–9). 
Epidemiological evidence and animal studies suggest that exposure to mainstream CS or 
environmental/sidestream CS (SS) during pregnancy adversely affects the pulmonary health 
of the offspring, including a higher risk for allergic asthma and airway remodeling (7, 10–
14) and bronchopulmonary dysplasia (BPD) (15–17). Moreover, CS exposure either during 
first (18) or third trimester (19) increases the risk of wheeze and asthma in children. We have 
reported that gestational exposure to SS promotes BPD-like alveolar simplification and 
marked exacerbation of allergen-induced Th2 polarization and severity of allergic asthma 
(AA) in mice (20, 21). Normal fetal development occurs under hypoxic conditions and 
HIF-1α is important for normal organogenesis (22, 23); however, HIF-1α expression is 
significantly reduced in gestationally SS-exposed animals (17). HIF-1α promotes 
angiogenesis and suppresses apoptosis; however, in utero SS-exposed mouse lungs have 
impaired angiogenesis and alveolarization and increased number of apoptotic epithelial cells 
in the airways (17, 21).
The prevalence of asthma in the US has been rising steadily, particularly among 0–4 yr-olds, 
where the incidence nearly tripled between 1980 and 1994 (24). Maternal smoking during 
pregnancy causes epigenetic changes, including methylation of some asthma-related genes 
(25). Increasing evidence suggest that lung diseases induced through in utero exposure to 
environmental toxins, are potentially transmitted transgenerationally (2, 3). Epidemiological 
evidence suggests that women smoking during pregnancy not only increase the risk of 
asthma in their unborn children but also among grandchildren (26). The mechanisms by 
which the transgenerational effects of smoking on asthma are manifested are not clear, but 
epigenetic mechanisms might be implicated (27). Moreover, perinatal exposure of rats to 
nicotine promotes development of asthma transgenerationally and the response is associated 
with decreased PPARγ through methylation of its promoter (28–30). In this communication, 
we show that gestational SS exacerbates AA and BPD transgenerationally through 
epigenetic mechanisms; however, the effects are independent of PPARγ but linked to 
specific microRNAs (miRs) that regulate apoptosis and angiogenesis.
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MATERIALS AND METHODS
Animals
Pathogen-free BALB/c mice (FCR Facility, Frederick, MD) were kept in exposure chambers 
and maintained at 26 ± 2°C and 12-hour light/dark cycle. Food and water were provided ad 
libitum. All animal protocols were approved by the Institutional Animal Care and Use 
Committee.
Reagents
Buffers and Precast gels for the Western blot analysis were obtained from Bio Rad 
Laboratories Inc. (Hercules, CA). Specifics for other reagents including antibodies are 
provided in the description of methods
Gestational exposure to sidestream cigarette smoke (SS)
Adult (3–4 month old) male and female mice were separately acclimatized to SS or filtered 
air (FA) for 2 weeks, and then paired for mating under the same exposure conditions. Mice 
were whole-body exposed to SS or FA for 6 hours/day, 7 days/week using Type 1300 
smoking machine (AMESA Electronics, Geneva, Switzerland) as described previously 
(Singh et al., 2013). The machine generated two 70 cm3 puffs/min from 2R1 cigarettes 
(Tobacco Health Research Institute, Lexington, KY). The dose of SS was approximately 
equivalent to the amount of SS a pregnant woman would receive by sitting in a smoking bar 
for 3 hr/day throughout the gestational period (21). After pregnancy was established, male 
mice were removed and the pregnant mice continued to receive SS or FA until the pups were 
born. Mice were sacrificed by an intraperitoneal injection of 0.2 ml Euthasol.
Sensitization with Aspergillus fumigatus proteins (Af)
Lyophilized culture filtrate preparation of Aspergillus fumigatus (Greer, Lenoir, NC) was 
used to elicit allergic response in the animals. Mice (7 weeks old) were immunized 
intratracheally with 0.1 ml Af (50 μg) in endotoxin-free sterile saline or sterile saline alone) 
and subsequently challenged intratracheally with 0.1 ml of Af (250 μg) three times at 5-day 
intervals (Singh et al., 2009). Control animals were given sterile saline.
Measurement of airway resistance and lung compliance
At 48 h after the last Af/saline administration, airway resistance (RL) and dynamic 
compliance (Cdyn) were measured by the FlexiVent system (SCIREQ, Montreal, Quebec, 
Canada). Briefly, mice were anesthetized by i.p. injection of avertin (250 mg/kg). A small 
incision was made in the trachea through which a 20-gauge needle hub was inserted and 
saline-filled catheter was placed in the esophagus via the mouth to obtain transthoracic 
pressure. The mouse was placed on the FlexiVent apparatus and ventilated through the 
tracheal cannula. Doxacurium (0.5 mg/kg) was administered i.p., and heart rate and 
electrocardiogram were monitored by a Grass Instruments Recorder with Tachograph. RL 
was assessed using increasing doses of aerosolized methacholine (MCh). RL and Cdyn were 
derived by manipulation of ventilatory patterns and measurement of upstream and 
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downstream pressures. The peak responses at each MCh concentration were used for data 
analysis.
Bronchoalveolar lavage fluid (BALF) collection, cell differential, and cytokine analysis
Established protocols were followed to obtain BALF. Briefly, mice were anesthetized and 
killed by exsanguination at 48 h post last Af challenge. Before excision of the lungs, the 
trachea was surgically exposed, cannulated and, while the left lung lobe was tied off with a 
silk thread, the right lobe was lavaged twice with 1 ml sterile Ca 2+/Mg2+ free PBS (pH 7.4). 
Aliquots were pooled from individual animals. Cell differentials and cytokines assays were 
performed as described previously (13, 20). Number of macrophages, neutrophils, 
lymphocytes, and eosinophils (Eos) was determined microscopically by counting at least 
300 cells/sample. BALF was analyzed for IL-13 and IFN-γ using the Mouse Cytokine 
ELISA kit (Biosource-Invitrogen, Camarillo, CA) according to the manufacturer’s 
directions. The sensitivity of the assay was <10 pg/ml.
Preparation of lung tissues
Mice were sacrificed and the left lung was inflated and kept in 10% formalin bath at 20 cm 
pressure for 24 h (21). After washing, the lungs were embedded in paraffin and 5 μm thick 
sections were cut for histopathology and immunohistochemistry. The right lung was quickly 
frozen in liquid-N2, and kept at −80°C for making lung homogenates and RNA.
Immunostaining
H&E staining was performed on deparaffinized tissue sections using standard protocols (21). 
Computer-selected random areas of H&E-stained lung sections were used to quantitate 
alveolar volumes using NanoZoomer Digital Pathology slide scanner (Hamamatsu K. K. 
Photonics, Hamamatsu City, Japan). The analysis was done blind.
Immunofluorescence staining for HIF-1α, NF-κB, and CD31
After deparaffinization, immunofluorescence (IF) staining was performed as described 
previously (17, 21). Lung sections were stained with anti-HIF-1α antibody (Cat#: ab16066, 
Abcam) or anti- phospho-p65-NF-κB (pRelA) antibody (Cat#: 3033, Cell Signaling Tech). 
The slides were counter stained with anti-rabbit Alexa 564-conjugated secondary antibody 
(Cat#: A-11010, Life Technologies). Staining for CD31 (endothelial cell marker) was 
performed using rabbit anti-CD31 antibody (Cat#: ab28364; Abcam) at 1:2,000 dilution 
followed by DyLight 549–conjugated anti-rabbit antibody (Singh et al., 2013). HIF-1α-, 
p65-, and CD31-positive cells in the lungs were counted blind using Axiplan 2 imaging 
(Hamamatsu, Japan) on computer selected 9000 μm2 areas. Nuclei were stained with DAPI 
(blue fluorescence). The procedure was repeated three times with different animals.
TUNEL Assay
To detect apoptotic cells, deparaffinized lung sections were stained using fluorescein In Situ 
Cell Death Detection kit (Cat#: 11 684 795 910; Roche Applied Science, Germany) as per 
manufacturer’s directions. TUNEL-positive cells were counted blinded.
Singh et al. Page 4
J Immunol. Author manuscript; available in PMC 2018 May 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
Western blot analysis
Western blot (WB) analysis of lung homogenates was carried out as described previously 
(18, 21). Briefly, tissue samples were homogenized in RIPA buffer and the protein content of 
the extracts was determined by the BCA Protein Assay Kit (Pierce, Rockford, IL). The 
homogenates were run on SDS-PAGE on 10% precast polyacrylamide gels (Bio Rad Lab, 
Hercules CA). The gels were transferred electrophoretically to nitrocellulose membranes 
(Bio Rad Lab). The blots were incubated with anti-PPARγ antibody (Cat#: sc-7273, Santa 
Cruz Biotech). The mouse anti-actin antibody (Santa Cruz Biotech) was used as a control for 
a house-keeping protein. After incubating with secondary antibody, immuno-detection was 
performed using Amersham ECL Western Blotting Detection Reagent (GE Healthcare Bio-
Science Corp. Piscataway, NJ) and the images were captured by Fujiform LAS-4000 
luminescent image analyzer (FUJIFILM Corporation, Tokyo). Densitometry was used to 
quantitate the expression of specific proteins and the ratio of PPARγ to actin.
Methylation analysis of PPARγ promoter
Methylation of the CpG island flanking the start site of PPARγ promotor was performed by 
direct pyrosequencing after bisulfite modification and PCR amplification (EpigenDx, 
Hopkinton, MA). Assays were pre-validated to ensure that there was no preferential 
amplification for either methylated or unmethylated DNA.
RT-qPCR for microRNA (miRs), GATA-3 and T-bet
Total RNA isolated from F1 and F2 lungs was used to quantitate miR-16, miR-221, and 
miR-130a using RNeasy Plus Kit (Qiagen). Stem-loop qPCR was used with specific primers 
and reagents and the PCR products were amplified using TaqMan MicroRNA Assay 
together with the TaqMan Universal PCR master Mix and AB StepOnePlus Real Time PCR 
System (Applied Biosystems). The lung expression of GATA-3, T-bet and GAPDH were 
determined using the One-Step RT-PCR Master Mix and specific labeled primers/probes set 
(Applied Biosystems, Foster City, CA). The relative expression of each mRNA was 
calculated as previously described (13).
Statistical analysis
Data were analyzed using Graph Pad Prism software 5.03 (Graphpad Software Inc., San 
Diego, CA). The student’s t test was used for comparison between two groups at 95% 
confidence interval. Results were expressed as the means (± SD). A p value of ≤0.05 was 
considered statistically significant.
RESULTS
Gestational SS alters airway resistance and lung compliance in F1 and F2 mice
Gestational SS exacerbates Af-induced AA through increase in airway hyperresponsiveness 
(13, 20). In current experiments, dams were exposed to fresh air (FA) or SS two weeks prior 
to pregnancy and throughout the gestational period. Progeny derived from these mice (F1) 
and from mating of F1 (F2) were tested by FlexiVent system for airway resistance (RL) and 
lung compliance (Cdyn) after Af sensitization. We tested a total of 8 FA- and 17 SS-exposed 
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mice from the F2 progeny of both sexes and compared their response to 6 FA- and SS-
exposed mice from F1 generation. The magnitude of increase in airway resistance (Fig. 1A) 
and decrease in lung compliance (Fig. 1B) was similar in F1 and F2 animals from the SS-
exposed dams. Thus, gestational SS exposure not only causes marked increase in airway 
hyperreactivity in F1 and F2, it also decreases lung compliance in both generations. 
Moreover, this transmission is independent of gender and exhibited by all the members of 
the F2 progeny. These results suggest that the inheritance of gestationally SS-induced 
asthma phenotype involves epigenetic rather than Mendelian genetic transmission.
Gestational SS increases allergen-induced Th2 and decreases Th1 markers in F1 and F2 
lungs
Gestational SS promotes Af-induced Th2 responses but decreases Th1 markers in F1 lungs 
(13, 20). To ascertain whether this propensity is transmitted to F2 progeny, following Af 
sensitization, BAL of F1 and F2 mice derived from FA- and SS-treated dams were analyzed 
for cellular composition and cytokine expression. Compared to FA, BAL from gestationally 
SS exposed mice had slightly but significantly higher number of total leukocytes in F1 (FA = 
7.4 ± 0.6 x 105; SS = 11.3 ± 1.5 x 105, p=0.001) and F2 (FA = 6.3 ± 1.4 x 105; SS = 8.7 
± 1.1 x 105, p=0.05); however, compared to FA, SS-exposed F1 and F2 mice exhibited a 
marked difference in the cellular composition of the BAL, including the percentage of 
eosinophils in F1 (FA: 7.0 ± 3.2; SS: 63.5 ± 10.8, p=0.001) and F2 (FA: 8.6 ± 3.2; SS: 67.2 
± 2.3, p=0.0001) and macrophages: F1 (FA: 85.4 ± 5.7; SS: 26.5 ± 8.9, p=0.001) and F2 
(FA: 81.3 ± 7.1; SS: 13.2 ± 3.8, p=0.0001). It is likely that decreased macrophages 
percentage in SS-exposed BAL reflects a large increase in the eosinophil count. 
Additionally, we measured the BAL levels of the Th2 cytokine IL-13 and the Th1 cytokine 
IFN-γ by ELISA (Fig. 2A) and the lung expression of the Th2 transcription factor GATA3 
and the Th1 transcription factor T-bet by qPCR (Fig. 2B). Together these results indicate that 
gestational SS promotes Th2 and suppresses Th1 responses in the lungs of F1 and F2 
progenies.
Gestational SS causes alveolar simplification and impairs angiogenesis in F1 and F2 lungs
Angiogenesis is critical for normal lung alveolarization (31) and we have shown that 
gestational SS impairs alveolarization and angiogenesis in the neonatal lung (17). We carried 
out similar experiments in F2 animals and compared the results with control (FA) and SS-
exposed F1 lungs. H&E staining for alveolar architecture (Fig. 3A) and alveolar volumes 
(Fig. 3B) of 10 weeks old lungs showed that, compared to FA, gestational SS significantly 
increases the alveolar volumes in F1 and F2 lungs. Moreover, as detected by 
immunohistochemistry for CD31 (Fig. 4A, left panel) and its quantitation (Fig. 4A, middle 
panel) and qPCR analysis of VEGFR2 (Fig. 4A, right panel), gestational SS impairs 
angiogenesis in both F1 and F2 lungs. Normal expression of NF-κB is critical for 
angiogenesis of the developing lung (Patel et al., 2005) and, as seen by IHC staining (Fig. 
4B, left panel) and its quantitation (Fig. 4B, right panel), nuclear expression of p65-NF-κB 
is strongly downregulated in the SS-exposed F1 and F2 lungs. In addition, as detected by 
TUNEL staining (Fig. 4C, left panel) and its quantitation (Fig. 4C, middle panel), 
gestational SS increases the number of apoptotic cells within the alveoli of F1 and F2 
progenies. The transcription factor RUNX3 promotes apoptosis (32) and, as measured by 
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qPCR analysis, its expression is markedly upregulated in gestationally SS-exposed F1 and 
F2 lungs (Fig. 4C right panel). These data suggest that the effects of gestational SS on lung 
angiogenesis, alveolar development, and apoptosis are transmitted from F1 to F2 generation.
Gestational SS decreases HIF-1α but not PPARγ expression in F1 and F2 progenies
It has recently been demonstrated in rats that daily perinatal injection of nicotine aggravates 
asthmatic responses transgenerationally and the effects are associated with decreased lung 
expression of PPARγ through increased PPARγ promoter methylation (29, 30, 33). To 
ascertain whether gestational SS exposure affected PPARγ in F1 and/or F2 lungs, we 
measured the mRNA and protein levels as well as promoter methylation of PPARγ in 
gestationally FA- and SS-exposed mouse lungs. Surprisingly, qPCR and Western blot 
analysis indicated that gestational SS did not significantly alter either the mRNA or protein 
levels of PPARγ in F1 or F2 lungs (Fig. 5A left and middle panel). Similarly, 
pyrosequencing analysis did not show significant changes in the methylation of PPARγ 
promoter (Fig. 5B). On the other hand, there was non-significant trend for higher levels of 
PPARγ mRNA and protein in gestationally SS-exposed F1 and F2 lungs. These results 
suggest that the asthma phenotype induced by gestational SS-exposures in F1 and F2 lungs 
is not associated with epigenetic changes in PPARγ levels.
HIF-1α controls angiogenesis as well as apoptosis and is significantly decreased in 
gestationally SS-exposed animals (17). We quantitated HIF-1α levels in the airways of F1 
and F2 animals by immunohistochemistry. Results show that HIF-1α levels are significantly 
decreased in the airways of gestationally SS-exposed F1 and F2 animals (Fig. 5C left and 
right panel). Thus, decreased HIF-1α levels are associated with asthma phenotype in F1 and 
F2 animals from gestationally SS-exposed mice.
Gestational SS affects miRs in F1 and F2 lungs that regulate angiogenesis and apoptosis
Gestational SS affects apoptosis and angiogenesis in the mouse lung (17, 21) and increasing 
evidence suggests that miRs regulate these processes. We ascertained the effects of 
gestational SS on some critical miRs that are known to regulate angiogenesis and apoptosis. 
miR 16 and miR 221 are known to increase apoptosis and autophagy and decrease 
proliferation and angiogenesis in various cell types (34–36). These miRs are increased in 
gestationally SS-exposed F1 and F2 mice (Fig. 5D left and middle panel). Conversely, the 
expression of miR-130a that targets the proapoptotic factor RUNX3 and inhibits autophagy, 
and stimulates angiogenesis and cell proliferation (37, 38), is significantly decreased in F1 
and F2 lungs from gestationally SS-exposed mice (Fig 5D, right panel). These results 
indicate that gestational SS affects the expression of pro- and anti-apoptotic/angiogenic 
miRs and these effects are transmitted to the next generation.
DISCUSSION
In recent decades, AA among children has been inexplicably increasing and asthma burden 
in the US exceeds $56 billion/year (39). In utero exposure to CS, prone children to allergic 
asthma and BPD (16, 18, 19). The asthma inducing effects of in utero CS exposure are 
associated with smoking by either parent, suggesting that exposure to environmental/SS 
Singh et al. Page 7
J Immunol. Author manuscript; available in PMC 2018 May 15.
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
A
uthor M
an
u
script
during pregnancy has the potential to affect AA in children. Moreover the grandmothers who 
smoke, elevate the risk of asthma in their nonsmoking granddaughters (26), highlighting the 
potential of transgenerational transmission of asthmatic phenotype induced by gestational 
SS exposure. Similarly, in a rat model of allergic asthma, Dr. Rehan’s laboratory clearly 
demonstrated that the pro-asthmatic effects of perinatal nicotine injections were transmitted 
to F2 and F3 progenies and the effects were dependent on PPARγ and moderated by PPARγ 
agonists (29, 33). We have previously shown that gestational exposure of mice to SS induces 
AA and BPD-like phenotypes in mice and the effects are dependent on nicotinic 
acetylcholine receptors and blocked by the allosteric antagonist of nAChRs mecamylamine 
(17, 21). Following gestational SS, the proasthmatic and lung architectural changes in F1 
mice are associated with Th2 polarization, increased apoptosis and decreased angiogenesis 
in the neonatal lung. In addition, gestational SS-induces changes in F1 lungs that are 
strongly correlated with desensitization of nAChRs and decreased levels of HIF-1α (17).
Results presented herein clearly suggest that the effects of gestational SS on AA and BPD 
are transmitted to F2 generation; this includes a striking increase in methacholine-induced 
airway hyperresponsiveness and a strong decrease in lung compliance in F1 and F2 
progenies. Asthma is mainly a Th2 inflammatory lung disease (40) and Th2 polarization is a 
hallmark of AA and asthma exacerbations (41). In mice, in utero exposure to CS causes 
strong Th2 polarization associated with significant increases in Th2 cytokines/Th2 
transcription factors and significant decreases in Th1 cytokines/Th1 transcription factors 
(20).To understand the mechanism by which gestational SS regulates transgenerational 
transmission of asthma phenotype, we analyzed allergen-induced changes in Th1 and Th2 
cytokines/transcription factors in F1 and F2 progenies derived from control and gestationally 
SS-exposed dams. Results indicate that SS exposure is associated with higher expression of 
Th2 cytokines/transcription factors such as IL-4, IL-13, and GATA3 and lower expression of 
Th1 cytokines/transcription factors (e.g., IFN-γ, T-bet). In addition, our preliminary 
unpublished results show that gestational SS causes a significant decrease in the lung TNF-α 
and increase in IL-10 in F1 and F2; IL-10 suppress Th1 responses through inhibition of 
TNF-α and IFN-γ (42). In addition, gestational SS-induced BPD-like changes in F1 to F2 
lungs are associated with decreased angiogenesis (lower expression of CD31, VEGF, and 
VEGFR2). Hypoxic conditions and HIF-1α are important for angiogenesis and normal fetal 
development (43); gestational SS downregulates HIF-1α and increases airway/alveolar 
epithelial cell apoptosis in both F1 and F2 lungs.
Because 100% of F2 animals tested (n = 17), derived from gestationally SS-exposed F1 
progeny, exhibited exacerbated asthma and BPD-like phenotype, ruled out the Mendelian 
mode of inheritance, suggesting that the transmission requires epigenetic mechanisms. 
Maternal smoking has been shown to cause DNA methylation and differential expression of 
thousands of genes some of which are related to asthma (25). Moreover, proasthmatic effects 
of perinatal nicotine (I mg/kg) were shown to be passed on to F2 and F3 generations and 
linked to decreased PPARγ activity through PPARγ gene methylation in alveolar fibroblasts 
(28, 30). Therefore, we determined whether gestational SS altered the expression of PPARγ 
mRNA and protein, or affected its phosphorylation or methylation. Surprisingly, none of 
these PPARγ parameters were significantly decreased in the lungs of F1 or F2 animals 
derived from gestationally SS-exposed dams. Moreover, although, PPARγ agonist 
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rosiglitazone was shown to moderate the proasthmatic effects of perinatal nicotine 
administration in rats (33,), PPARγ ligands such as rosiglitazone, pioglitazone, and 
troglitazone are known to inhibit VEGF-induced angiogenesis (44, 45), but lung VEGF and 
lung angiogenesis are significantly decreased in the gestationally SS-exposed animals (17 
and data presented herein). On the other hand, there is a trend for higher expression of 
PPARγ in F1 and F2 lungs from gestationally SS-derived animals and, as discussed later, 
miR-130a that targets PPARγ (46) is decreased in these lungs. Thus, it is highly unlikely 
that the proasthmatic transgenerational effects of gestational SS are regulated by PPARγ 
activity. Therefore, it is conceivable that, while both perinatal nicotine injections (29) and 
gestational SS inhalation (21) promote asthma in F1 and F2 progenies, the two treatments 
may employ distinct mechanisms.
One of the major epigenetic mechanisms for regulation of gene expression involves changes 
in levels of miRs (47); these non-coding RNAs bind and degrade specific mRNAs (48). 
Nicotine normally promotes cell proliferation through inhibition of apoptosis and 
stimulation of angiogenesis through upregulation of HIF-1α (49); however, gestational SS 
downregulates HIF-1α in the lung through desensitization of nAChRs (17, 21). Because 
gestational SS-induced changes in HIF-1α are intimately correlated with asthma and BPD in 
both F1 and F2, we analyzed the expression of some miRs that are known to control 
angiogenesis and apoptosis and affect HIF-1α levels in the lung (Fig. 6). Of the miRs tested, 
we observed significant changes in the expression of 3 miRs in both SS-derived F1 and F2 
lungs. The expression of miR-16 and miR-221 was significantly elevated and these miRs 
target and decrease proapoptotic factors such as BIM-BAX, BAK (50–52); BIM, BIK, BAX, 
and BAK are increased in gestationally SS-exposed lungs (17). ZEB2 promotes epithelial-
mesenchymal-transition (EMT) through downregulation of p53 and upregulation of Akt (53, 
54) and inhibits the anti-angiogenic factor GAX (52). Although, as yet, we do not have 
direct evidence to show that gestational SS affects ZEB2; however, GAX and p53 are 
strongly upregulated and Akt is downregulated in SS-derived F1/F2 lungs (17 and data 
presented herein). Moreover, our preliminary results suggest that EMT is suppressed in SS-
exposed lungs (Singh et al., unpublished results). Gestational SS decreases miR-130a that 
targets the anti-angiogenic factor GAX and the proapoptotic factor RUNX3 (37, Lee et al., 
2015); both GAX and RUNX3 are increased in F1 and F2 lungs from gestationally SS-
exposed mice. Furthermore, RUNX transcription factors have been implicated in predicting 
asthma associated with maternal smoking (55). miR-130a also promotes VEGF synthesis 
indirectly by targeting VEGF inhibitor Hoxa5. Although as yet we don’t know whether 
Hoxa5 is upregulated in gestationally SS-exposed lungs, levels of VEGF are markedly 
reduced in both F1 and F2 lungs. It should be emphasized that we only examined the 
miRNAs that have been linked to HIF-1α; however, it is likely that gestational SS affects 
other miRNAs, whose potential effects on AA and BPD remain to be ascertained.
Nicotine/CS normally downregulates Th2 responses (e.g., allergic asthma, ulcerative colitis) 
and exacerbates Th1 diseases (56, 57); however, desensitization of nAChRs during 
gestational nicotine/SS exposure might reverse this pattern (17). In keeping with this 
prediction, F1 and F2 lungs from gestationally SS-exposed animals show higher Th2 and 
lower Th1 responses. Together our results suggest that the effects of gestational SS on AA 
and BPD are transmitted from F1 to F2 generations through epigenetic mechanisms, and 
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changes in specific miRs might contribute to this response by regulating the nAChR-HIF-1α 
pathway. These possibilities are presented as a tentative schematic pathway in Fig. 6. 
Participation of other epigenetic mechanisms in regulating AA and BPD responses to 
gestational nicotine, such as DNA methylation and histone modifications can’t be ruled out 
at this time.
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Fig. 1. Transgenerational effects of gestational SS on airway hyperreactivity and dynamic lung 
compliance
Lung resistance (RL) was measured using FlexiVent system in response to: (A), increasing 
doses of computer-controlled nebulized methacholine (MCh), (B), dynamic lung compliance 
(Cdyn), which reflects lung compliance at any given time during actual movement of air. 
Determination of RL and Cdyn was carried after Af-sensitization as described in Methods. 
The results are representative of two different sets of inhalation exposures. Data are 
expressed as mean ± SD (n = 6 –17/group). * ≤ p = 0.05; FA = filtered air, SS = sidestream 
cigarette smoke; F1: first generation; F2 second generation.
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Fig. 2. Transgenerational effect of gestational SS-exposure on Th1/Th2 cytokines/transcription 
factors
A: BALF levels of IL-13 (left panel) and IFN-γ ((right panel) were determined by the 
Mutiplex ELISA kit. B: Lung levels of GATA 3 (left panel) and T-bet (right panel) were 
determined by quantitative RT-PCR analysis total lung RNA from mice sensitized with Af as 
described in the Methods section. Results are representative of animal responses from two 
different sets of inhalation exposures. Data are expressed as mean ± SD (n = 5–7/group. FA 
= filtered air, SS = secondhand cigarette smoke; F1: first generation; F2 second generation.
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Fig. 3. Gestational SS-induced alveolar simplification is exhibited by F1 and F2 lungs
A: H&E stained lung sections (5 um) from F1 and F2 mice; B: quantitation of alveolar 
volumes. The results are representative of animal responses from two different sets of 
inhalation exposures. Data are expressed as mean ± SD (n =6 –17/group. FA = filtered air, 
SS = secondhand cigarette smoke; F1: first generation; F2 second generation.
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Fig. 4. Gestational SS-exposure downregulates angiogenesis, VGEFR2, p65-NFκB, and 
upregulates apoptosis in F1 and F2 lungs
A: Lung sections were stained with anti-CD3 antibody (left anel) and the red florescent cells 
were quantitated microscopically (middle panel); expression of VEGEFR2 was done by 
qPCR analysis (right panel).B: Lung sections were stained with phosphorylated(p)-anti-p-65 
antibody (left panel) and p-65-positive cells were quantitated (right panel). C: Lung sections 
were stained for TUNEL-positive cells using In Situ cell Death Detection kit (left panel) and 
quantitated microscopically (middle panel); RUNX3 levels were determined by quantitative 
RT-PCR using total lung RNA. Where indicated slides were counterstained with DAPI to 
visualize nuclei. Results are representative of animal responses from two different sets of 
inhalation exposures. Data are expressed as mean ± SD (n = 5–7/group. FA = filtered air, SS 
= secondhand cigarette smoke; F1: first generation; F2 second generation.
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Fig. 5. Effects of gestational SS on PPARγ, HIF-1α and miRs in F1 and F2 lungs
A: Quantitation of PPARγ by quantitative RT-PCR of total lung RNA (left panel); Western 
blot analysis of lung homogenates for PPARγ (middle panel) and ratio of PPARγ : actin 
from the Western blots by densitometry (right panel). B: percent methylation of PPARγ 
promoter (left panel C: Immunofluorescent staining of lung sections for HIF-1α with DAPI 
for nuclear staining (left panel) and quantitation of HIF-1α-positive cells (right panel). D 
Quantitative RT-PCR analysis for miR-16 (left panel), miR-221 (middle panel), and 
miR-130a (right panel). Data are normalized with snRNA U6. The results are representative 
of animal responses from two different sets of inhalation exposures. Data are expressed as 
mean ± SD (n = 5–7/group. FA = filtered air, SS = secondhand cigarette smoke; F1: first 
generation; F2 second generation.
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Fig. 6. A tentative schematic diagram showing possible pathways eliciting the effect of gestational 
SS exposure
Desensitization of nAChRs during gestational nicotine/SS-exposure affects HIF-1α levels 
increasing apoptosis and decreasing angiogenesis in the lung. The expression of pro-
apoptotic miRs (miR-16 and miR-221) is significantly elevated in gestationally SS-exposed. 
Gestational SS-exposure decreases miR-130a that targets the anti-angiogenic factor GAX 
and the proapoptotic factor RUNX3 (both GAX and RUNX3 are increased in F1 and F2 
lungs). Red arrows indicate established responses with upward arrows indicating significant 
increase and downward arrows indicating significant decrease in the indicated response. 
Components in the pathway that are without the arrows predict the indicated response but 
remain hitherto unproven.
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